Bio-Rad Laboratories (BIO) EBT Growth (1y) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 54.33% |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | -927.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -927.10% |
| Dec 31, 2025 | 202.23% |
| Sep 30, 2025 | -150.03% |
| Jun 30, 2025 | 114.86% |
| Mar 31, 2025 | -83.02% |
| Dec 31, 2024 | -312.16% |
| Sep 30, 2024 | 528.45% |
| Jun 30, 2024 | -85.70% |
| Mar 31, 2024 | 478.93% |
| Dec 31, 2023 | -60.75% |
| Sep 30, 2023 | 166.13% |
| Jun 30, 2023 | -22.97% |
| Mar 31, 2023 | 101.94% |
| Dec 31, 2022 | 153.84% |
| Sep 30, 2022 | -104.13% |
| Jun 30, 2022 | -205.48% |
| Mar 31, 2022 | -436.72% |
| Dec 31, 2021 | -286.16% |
| Sep 30, 2021 | 198.15% |
| Jun 30, 2021 | -7.15% |
| Mar 31, 2021 | 44.34% |
| Dec 31, 2020 | 55.70% |
| Sep 30, 2020 | 602.50% |
| Jun 30, 2020 | 61.90% |
| Mar 31, 2020 | -20.28% |
| Dec 31, 2019 | 167.17% |
| Sep 30, 2019 | -195.75% |
| Jun 30, 2019 | 126.30% |
| Mar 31, 2019 | 30.52% |
| Dec 31, 2018 | -2,368.42% |
| Sep 30, 2018 | 1,044.57% |
| Jun 30, 2018 | 30,264.82% |
| Mar 31, 2018 | 4,197.01% |
| Dec 31, 2017 | 263.11% |
| Sep 30, 2017 | 34.75% |
| Jun 30, 2017 | -95.84% |
| Mar 31, 2017 | -0.50% |
| Dec 31, 2016 | -151.92% |
| Sep 30, 2016 | -10.68% |
| Jun 30, 2016 | -31.97% |
| Mar 31, 2016 | -24.33% |
| Dec 31, 2015 | 18.48% |
| Sep 30, 2015 | 13.08% |
| Jun 30, 2015 | -18.97% |
| Mar 31, 2015 | 83.62% |
| Dec 31, 2014 | 2.78% |
| Sep 30, 2014 | 530.90% |
| Jun 30, 2014 | -0.50% |
| Mar 31, 2014 | -39.54% |
| Dec 31, 2013 | -24.76% |
| Sep 30, 2013 | -109.48% |
| Jun 30, 2013 | -25.71% |
| Mar 31, 2013 | -47.93% |
| Dec 31, 2012 | -29.57% |
| Sep 30, 2012 | -1.38% |
| Jun 30, 2012 | 14.18% |
| Mar 31, 2012 | -4.31% |
| Dec 31, 2011 | 46.84% |
| Sep 30, 2011 | -3.69% |
| Jun 30, 2011 | 4.45% |
| Mar 31, 2011 | -3.13% |
| Dec 31, 2010 | 35.89% |
| Sep 30, 2010 | 13.06% |
| Jun 30, 2010 | 12.34% |